Entry |
|
Name |
Tazomeline citrate (USAN) |
Formula |
C14H23N3S2. C6H8O7
|
Exact mass |
489.1603
|
Mol weight |
489.61
|
Structure |

|
Class |
Neuropsychiatric agent
DG01490 Muscarinic cholinergic receptor agonist
|
Efficacy |
Dementia therapeutic agent, Muscarinic acetylcholine receptor agonist |
Comment |
Alzheimer's disease treatment
|
Target |
|
Pathway |
hsa04080 | Neuroactive ligand-receptor interaction |
|
Interaction |
|
Brite |
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01490 Muscarinic cholinergic receptor agonist
D06015 Tazomeline citrate
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Acetylcholine (muscarinic)
CHRM
D06015 Tazomeline citrate (USAN)
|
Other DBs |
|
LinkDB |
|
KCF data |
ATOM 32
1 C1d C 23.1700 -16.0300
2 C1b C 21.9800 -16.6600
3 C1b C 24.3600 -16.6600
4 C6a C 23.8700 -14.7700
5 O1a O 22.4700 -14.7700
6 C6a C 20.7900 -16.0300
7 C6a C 24.3600 -18.0600
8 O6a O 23.1700 -13.5800
9 O6a O 25.2700 -14.7700
10 O6a O 19.5300 -16.7300
11 O6a O 20.7900 -14.6300
12 O6a O 25.6200 -18.7600
13 O6a O 23.1700 -18.7600
14 N1y N 4.4800 -16.3800
15 C1x C 4.4800 -17.7800
16 C1x C 5.6924 -18.4800
17 C2x C 6.9049 -17.7800
18 C2y C 6.9049 -16.3800
19 C1x C 5.6924 -15.6800
20 C1a C 3.2676 -15.6800
21 C8y C 8.1360 -15.6690
22 C8y C 9.2697 -16.4788
23 N5x N 10.3865 -15.6516
24 S2x S 9.9448 -14.3339
25 N5x N 8.5551 -14.3467
26 S2a S 9.2109 -17.8494
27 C1b C 10.4131 -18.6141
28 C1b C 11.6652 -17.9611
29 C1b C 12.8774 -18.7317
30 C1b C 14.1089 -18.0893
31 C1b C 15.2984 -18.8461
32 C1a C 16.5713 -18.1825
BOND 32
1 1 2 1
2 1 3 1
3 1 4 1
4 1 5 1
5 2 6 1
6 3 7 1
7 4 8 1
8 4 9 2
9 6 10 1
10 6 11 2
11 7 12 1
12 7 13 2
13 14 15 1
14 15 16 1
15 16 17 1
16 17 18 2
17 18 19 1
18 14 19 1
19 14 20 1
20 18 21 1
21 21 22 1
22 22 23 2
23 23 24 1
24 24 25 1
25 21 25 2
26 22 26 1
27 26 27 1
28 27 28 1
29 28 29 1
30 29 30 1
31 30 31 1
32 31 32 1
|